Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Hwang

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|September 19, 2024
Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapyKaram Ashouri, Brian Hom, Anush A Ginosyan, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2026
Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell TransplantationAnush A Ginosyan, Karam Ashouri, Tiffany Chen, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|September 19, 2024
Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapyKaram Ashouri, Brian Hom, Anush A Ginosyan, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2026
Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell TransplantationAnush A Ginosyan, Karam Ashouri, Tiffany Chen, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.
Pageof 4